INS and cancer: Further effects attributed to CDR1as, potentially conveyed via other downstream targets, include the promotion of insulin secretion in islet cells upon overexpression of CDR1as, a potential role in cardiomyocyte apoptosis in diabetic cardiomyopathy, as well as the modulation of migratory and proliferative effects in cancer and non-cancer cells [20,21,22,23].